Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment

The Journal of Clinical Investigation
Kazuhiro TanakaEiji Kohmura

Abstract

The mechanistic target of rapamycin (mTOR) is hyperactivated in many types of cancer, rendering it a compelling drug target; however, the impact of mTOR inhibition on metabolic reprogramming in cancer is incompletely understood. Here, by integrating metabolic and functional studies in glioblastoma multiforme (GBM) cell lines, preclinical models, and clinical samples, we demonstrate that the compensatory upregulation of glutamine metabolism promotes resistance to mTOR kinase inhibitors. Metabolomic studies in GBM cells revealed that glutaminase (GLS) and glutamate levels are elevated following mTOR kinase inhibitor treatment. Moreover, these mTOR inhibitor-dependent metabolic alterations were confirmed in a GBM xenograft model. Expression of GLS following mTOR inhibitor treatment promoted GBM survival in an α-ketoglutarate-dependent (αKG-dependent) manner. Combined genetic and/or pharmacological inhibition of mTOR kinase and GLS resulted in massive synergistic tumor cell death and growth inhibition in tumor-bearing mice. These results highlight a critical role for compensatory glutamine metabolism in promoting mTOR inhibitor resistance and suggest that rational combination therapy has the potential to suppress resistance.

References

Jun 19, 2001·NMR in Biomedicine·S W Provencher
Oct 17, 2002·Journal of Neurology·M C TartagliaD L Arnold
Nov 12, 2005·The New England Journal of Medicine·Ingo K MellinghoffPaul S Mischel
Apr 11, 2006·Molecular Cell·Dos D SarbassovDavid M Sabatini
Jul 7, 2007·Cancer Cell·David A Guertin, David M Sabatini
Jan 8, 2008·Cell Metabolism·Ralph J DeBerardinisCraig B Thompson
Jun 10, 2008·Cancer Cell·Guido Kroemer, Jacques Pouyssegur
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Dec 1, 2009·Current Opinion in Cell Biology·Alejo Efeyan, David M Sabatini
Jun 24, 2010·Trends in Biochemical Sciences·David R Wise, Craig B Thompson
Jul 31, 2010·Molecular Cell·Katrin DüvelBrendan D Manning
Sep 14, 2010·Cancer Cell·Jian-Bin WangRichard A Cerione
Sep 24, 2010·Nature Reviews. Molecular Cell Biology·Marisa R Buchakjian, Sally Kornbluth
Nov 4, 2010·Cancer Research·Meghan J SeltzerGregory J Riggins
Oct 12, 2011·Annual Review of Cell and Developmental Biology·Sophia Y Lunt, Matthew G Vander Heiden
Nov 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·David R WiseCraig B Thompson
Mar 3, 2012·Cancer Science·Tomoo YoshieMasaru Yoshida
Mar 24, 2012·Cancer Cell·Patrick S Ward, Craig B Thompson
Apr 13, 2012·Molecular Cancer Therapeutics·William P KattRichard A Cerione
Jul 4, 2012·Molecular Cell·Raúl V DuránMichael N Hall
Nov 3, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Natalie E SimpsonIgor P Pogribny
Jan 30, 2013·Cell Research·Weijiao HuangYigong Shi
Mar 5, 2013·Journal of Neuro-oncology·Satoshi NakamizoEiji Kohmura
May 3, 2013·Nature·Haijuan YangNikola P Pavletich
Sep 14, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Beatrice GiniPaul S Mischel

❮ Previous
Next ❯

Citations

Oct 1, 2015·International Journal of Cancer. Journal International Du Cancer·Ulf D KahlertCharles G Eberhart
Sep 25, 2015·International Journal of Molecular Sciences·Lian Chen, Hengmin Cui
Feb 20, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lili GuoChangyu Wang
Dec 9, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yubin LiDianwen Ju
Feb 27, 2016·Journal of the American Chemical Society·Min XueJames R Heath
Nov 26, 2015·Oncogene·L JinS Kang
May 25, 2016·Biochemical and Biophysical Research Communications·Manabu NagaoKen-Ichi Hirata
Oct 27, 2015·The FEBS Journal·Elodie Villa, Jean-Ehrland Ricci
Nov 3, 2016·Nature Reviews. Clinical Oncology·Michelle M KimSriram Venneti
Aug 6, 2016·Nature Reviews. Cancer·Brian J AltmanChi V Dang
Aug 17, 2016·Nature Reviews. Immunology·Daniel E SpeiserGrégory Verdeil
Nov 9, 2016·Scientific Reports·Yasuhiro IrinoKen-Ichi Hirata
Apr 26, 2017·British Journal of Cancer·Emma R Still, Mariia O Yuneva
Jan 19, 2017·Cell Reports·Milica MomcilovicDavid B Shackelford
Jul 4, 2017·Nature Communications·Douglas E BiancurAlec C Kimmelman
Dec 8, 2017·Biomolecules & Therapeutics·Yeon-Kyung Choi, Keun-Gyu Park
Apr 27, 2016·World Journal of Stem Cells·Susumu KohnoChiaki Takahashi
Nov 29, 2017·Journal of Experimental & Clinical Cancer Research : CR·Claudia AbbruzzeseMarco G Paggi
Oct 3, 2018·Expert Opinion on Therapeutic Patents·CanRong WuHua Li
Mar 11, 2018·Clinical Science·Alberto M MartelliJames A McCubrey
Apr 4, 2019·American Journal of Respiratory Cell and Molecular Biology·Huachun CuiGang Liu
Apr 27, 2019·Neurochemical Research·Thomas N SeyfriedPurna Mukherjee
Jun 30, 2016·The Biochemical Journal·Rui CuriPaulo Ivo Homem de Bittencourt
Dec 17, 2019·Antioxidants & Redox Signaling·Natalie Y L NgoiAndrea L A Wong
May 12, 2020·Medicinal Research Reviews·Moges Dessale AsmamawHong-Min Liu
Nov 2, 2016·Oncotarget·Alenoush VartanianGelareh Zadeh
Jul 7, 2019·Journal of Hematology & Oncology·Hui HuaYangfu Jiang
Jul 16, 2016·Cancer & Metabolism·Johannes C van der MijnJames W Mier
Mar 11, 2017·Neurochemical Research·Javier MárquezJosé A Campos-Sandoval
Mar 17, 2017·Annual Review of Biomedical Engineering·Lifeng YangDeepak Nagrath
May 12, 2017·Frontiers in Cell and Developmental Biology·Marie Strickland, Elizabeth A Stoll
Apr 13, 2017·Arthritis Research & Therapy·Soshi TakahashiAkio Morinobu
Sep 17, 2020·Cells·Niccolo' RodaMarco Giorgio
Mar 28, 2017·The Journal of Clinical Investigation·Arimichi OkazakiOthon Iliopoulos
Jan 10, 2017·Annual Review of Pathology·Sriram Venneti, Craig B Thompson
Jun 6, 2017·Journal of Experimental & Clinical Cancer Research : CR·Zoltán HujberAnna Sebestyén

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
transfection
xenografts
PCR
Assay

Software Mentioned

Soft Imaging System
P Plus
SIMCA

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Akio IwanamiPaul S Mischel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Evanthia GalanisNorth Central Cancer Treatment Group
© 2021 Meta ULC. All rights reserved